Open for bids Tender Czech Republic ICB TOT Ref. 152647180

Medicinal Product of Atc Group L04ac24 Tender - 152647180

Tender notice from Czech Republic, published on 18 Nov 2026.

Executive Summary

Title/Summary: Tender for pharmaceutical supplies titled 'MIRIKIZUMAB' issued by Nemocnice Pardubického kraje, a.s. in Pardubice, Czech Republic. The estimated value of the contract is 5,861,437 CZK, with a completion period of 4 years. Submission deadline is December 18, 2026.

Scope Of Work: The scope of this tender involves securing continuous supplies of medicinal products classified under ATC group L04AC24 containing the active ingredient MIRIKIZUMAB. The duration of the contract is set for 4 years, ensuring a steady provision of these pharmaceuticals to meet healthcare needs.

Qualification Criterion: Bidders must demonstrate relevant experience in supplying pharmaceutical products. They are required to submit documentation proving their capability to deliver the specified medicinal products, including compliance with applicable health regulations and standards. Registration in relevant procurement databases may also be mandated.

Key facts

Summary
Medicinal Product of Atc Group L04ac24 with the Active Substance Mirikizumab
TOT Ref. No.
152647180
Document Ref. No.
Login to see
Country
Czech Republic
Notice type
Tender
Competition
ICB
Publication date
18 Nov 2026
Bid deadline
18 Dec 2026
EMD
Refer Document
Tender value
CZK 5861437
Purchaser ownership
Public
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Tender details are for registered users

Login to see details

Documents

Tender Notice
Login to view

Similar tenders

Tender Country TOT Ref. No. Bid deadline
Medicinal Product of Atc Group L03ab13 with the Active Ingredient Peginterferon Beta-1A Czech Republic 152644383 18 Dec 2026
Medicinal Product of Atc Group R03dx10 with the Active Substance Benralizumab Czech Republic 152641430 18 Dec 2026
Medicinal Product of Atc Group S01ba01 with the Active Substance Dexamethason Czech Republic 152641319 18 Dec 2026
Accessories for Pipettes Czech Republic 152607428 23 Nov 2026
Framework Agreement: Consumables 2027 - 2028 Czech Republic 152606964 26 Nov 2026

Czech Republic Public Procurement Intelligence

Frequently asked questions

The last date to submit a bid for Medicinal Product of Atc Group L04ac24 with the Active Substance Mirikizumab is 18 Dec 2026. Submit before this date to be considered.

This tender has been issued by PARDUBICE REGION HOSPITAL, A.S. in Czech Republic.

The estimated tender value is CZK 5861437. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 33600000 - Pharmaceutical products.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 152647180. The purchaser document reference is available after login.

See the Similar Tenders section on this page or browse other tenders from Czech Republic.

This tender falls under Materials and Products, Technology and Equipment in Czech Republic. Suppliers in these sectors can track similar Czech Republic tenders using CPV-based alerts.